SCHEMBL1653017

SCHEMBL1653017

Cc1ccc(OC(=O)N2CCC(c3nc(-c4ccc(F)cc4)co3)CC2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.42
FAAH O00519 6/20 0.39
LMNA P02545 4/20 0.38
HTT P42858 3/20 0.38
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38
TRPC3 Q13507 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TRPC7 Q9HCX4 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SPR P35270 2/20 0.38
LIPE Q05469 1/20 0.37
DYRK1A Q13627 1/20 0.37
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10040646 0.91 FAAH (0.43) GPR119FAAHLMNAHTTKDM4E
SCHEMBL10040536 0.91 SPR (0.45) FAAHLMNAKDM4ESMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL1653033 0.90 SPR (0.45) FAAHLMNAKDM4ESMN1; SMN2NPC1
SCHEMBL10040645 0.89 FAAH (0.40) FAAHHPGDHSD17B10TSHRALDH1A1
SCHEMBL10040650 0.88 HDAC1 (0.40) GPR119FAAHSMN1; SMN2MEN1KMT2A
SCHEMBL10040647 0.83 SMO (0.40) GPR119FAAHLMNAHTTKDM4E
SCHEMBL10040555 0.83 LMNA (0.55) LMNAHTTSMN1; SMN2TSHRALDH1A1
SCHEMBL1652158 0.83 GPR119 (0.45) GPR119FAAHLMNATP53NPC1
SCHEMBL10040552 0.82 MAPT (0.53) GPR119FAAHTP53MAPTKMT2A
SCHEMBL10040562 0.80 SMN1; SMN2 (0.46) GPR119FAAHLMNAHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2308869-B1 AZOLE COMPOUND ASTELLAS PHARMA INC (JP) 2012-09-19 EP claimed
US-8207199-B2 Azole compound ASTELLAS PHARMA INC. (JP) 2012-06-26 US claimed
US-20110118311-A1 AZOLE COMPOUND ASTELLAS PHARMA INC. (JP) 2011-05-19 US claimed
EP-2308869-A1 AZOLE COMPOUND Astellas Pharma Inc. (JP) 2011-04-13 EP claimed
EP-2308869-B1 AZOLE COMPOUND ASTELLAS PHARMA INC (JP) 2012-09-19 EP disclosed
EP-2308869-B1 AZOLE COMPOUND ASTELLAS PHARMA INC (JP) 2012-09-19 EP disclosed
US-8207199-B2 Azole compound ASTELLAS PHARMA INC. (JP) 2012-06-26 US disclosed
US-8207199-B2 Azole compound ASTELLAS PHARMA INC. (JP) 2012-06-26 US disclosed
US-8207199-B2 Azole compound ASTELLAS PHARMA INC. (JP) 2012-06-26 US disclosed
US-20110118311-A1 AZOLE COMPOUND ASTELLAS PHARMA INC. (JP) 2011-05-19 US disclosed
US-20110118311-A1 AZOLE COMPOUND ASTELLAS PHARMA INC. (JP) 2011-05-19 US disclosed
US-20110118311-A1 AZOLE COMPOUND ASTELLAS PHARMA INC. (JP) 2011-05-19 US disclosed
EP-2308869-A1 AZOLE COMPOUND Astellas Pharma Inc. (JP) 2011-04-13 EP disclosed
WO-2010007966-A1 AZOLE COMPOUND アステラス製薬株式会社 (JP) 2010-01-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118311-A1 AZOLE COMPOUND FAAH, FAAH2, TRPV1 GPR119 159/4885FAAH 1/4885LMNA 4326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.